β2-Adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis

Osteoarthritis and Cartilage

Volumn 18, Issue 4, 2010, Pages 555-562

  Tonge, D P ^a   Jones, S W ^b   Parr, T ^a   Bardsley, R ^a   Doherty, M ^c   Maciewicz, R A ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

2 adrenergic agonist; Beta agonist; Clenbuterol; Dysfunction; Hypertrophy; Meniscectomy; MHC; MNX; Myosin heavy chain; OA; Osteoarthritis; Quadriceps

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; MYOSIN HEAVY CHAIN; SODIUM CHLORIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; GROWTH RATE; HISTOPATHOLOGY; KNEE OSTEOARTHRITIS; MALE; MENISCECTOMY; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; RAT; RODENT; WEIGHT BEARING; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HYPERTROPHY; LEWIS RAT; OSTEOARTHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; BODY WEIGHT; CLENBUTEROL; DISEASE MODELS, ANIMAL; HYPERTROPHY; MALE; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; OSTEOARTHRITIS; QUADRICEPS MUSCLE; RATS; RATS, INBRED LEW; WEIGHT-BEARING;

EID: 77950020913     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.11.014     Document Type: Article

References (53)

1. Becker R., Berth A., Nehring M., Awiszus F. Neuromuscular quadriceps dysfunction prior to osteoarthritis of the knee. J Orthop Res 2004, 22:768-773.
2. Hurley M. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis Clin North Am 1999, 25:283.
3. Slemenda C., Heilman D., Brandt K., Katz B., Mazzuca S., Braunstein E., et al. Reduced quadriceps strength relative to body weight - a risk factor for knee osteoarthritis in women?. Arthritis Rheum 1998, 41:1951-1959.
4. Brandt K., Heilman D., Slemenda C., Katz B., Mazzuca S., Braunstein E., et al. Quadriceps strength in women with radiographically progressive osteoarthritis of the knee and those with stable radiographic changes. J Rheumatol 1999, 26:2431-2437.
5. Brandt K., Heilman D., Slemenda C., Katz B., Mazzuca S., Braunstein E., et al. A comparison of lower extremity muscle strength, obesity, and depression scores in elderly subjects with knee pain with and without radiographic evidence of knee osteoarthritis. J Rheumatol 2000, 27:1937-1946.
6. Ikeda S., Tsumura H., Torisu T. Age-related quadriceps-dominant muscle atrophy and incident radiographic knee osteoarthritis. J Orthop Sci 2005, 10:121-126.
7. Mikesky A., Mazzuca S., Brandt K., Perkins S., Damush T., Lane K. Effects of strength training on the incidence and progression of knee osteoarthritis. Arthritis Rheum 2006, 55:690-699.
8. Eyigor S. A comparison of muscle training methods in patients with knee osteoarthritis. Clin Rheumatol 2004, 23:109-115.
9. Mohammadi F., Taghizadeh S., Ghaffarinejad F., Khorrami M., Sobhani S. Proprioception, dynamic balance and maximal quadriceps strength in females with knee osteoarthritis and normal control subjects. Int J Rheum Dis 2008, 11:39-44.
10. Longino D., Frank C., Leonard T., Vaz M., Herzog W. Proposed model of botulinum toxin-induced muscle weakness in the rabbit. J Orthop Res 2005, 23:1411-1418.
11. Hayes K., Song J., Dunlop D., Cahue S., Sharma L. The quadriceps/hamstring ratio and protection against patellofemoral osteoarthritis progression. Arthritis Rheum 2002, 46:S142.
12. Slemenda C., Brandt K., Heilman D., Mazzuca S., Braunstein E., Katz B., et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med 1997, 127:97.
13. Marks R., Kumar S., Semple J., Percy J. Quadriceps femoris activation in healthy women with genu varum and women with osteoarthritis and genu varum. J Electromyogr Kinesiol 1994, 4:153-160.
14. Longino D., Frank C., Herzog W. Acute botulinum toxin-induced muscle weakness in the anterior cruciate ligament-deficient rabbit. J Orthop Res 2005, 23:1404-1410.
15. Mills P., Wang Y., Cicuttini F., Stoffel K., Stachowiak G., Podsiadlo P., et al. Tibio-femoral cartilage defects 3-5 years following arthroscopic partial medial meniscectomy. Osteoarthritis Cartilage 2008, 16:1526-1531.
16. Ericsson Y.B., Roos E.M., Dahlberg L. Muscle strength, functional performance, and self-reported outcomes four years after arthroscopic partial meniscectomy in middle-aged patients. Arthritis Rheum 2006, 55:946-952.
17. Lohmander L., Englund P., Dahl L., Roos E. The long-term consequence of anterior cruciate ligament and meniscus injuries - osteoarthritis. Am J Sports Med 2007, 35:1756-1769.
18. Thorstensson C., Petersson I., Jacobsson L., Boegard T., Roos E. Reduced functional performance in the lower extremity predicted radiographic knee osteoarthritis five years later. Ann Rheum Dis 2004, 63:402-407.
19. Segal N.A., Torner J.C., Felson D., Niu J., Sharma L., Lewis C.E., et al. Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort. Arthritis Care Res 2009, 61:1210-1217.
20. Amin S., Baker K., Niu J., Clancy M., Goggins J., Guermazi A., et al. Quadriceps strength and the risk of cartilage loss and symptom progression in knee osteoarthritis. Arthritis Rheum 2009, 60:189-198.
21. Sharma L., Dunlop D.D., Song J., Hayes K.W. Quadriceps strength and osteoarthritis progression in maligned and lax knees. Ann Intern Med 2003, 138:613-619.
22. Keefe F., Blumenthal J., Baucom D., Affleck G., Waugh R., Caldwell D., et al. Effects of spouse-assisted coping skills training and exercise training in patients with osteoarthritic knee pain: a randomized controlled study. Pain 2004, 110:539-549.
23. Diracoglu D., Aydin R., Baskent A., Celik A. Effects of kinesthesia and balance exercises in knee osteoarthritis. J Clin Rheumatol 2005, 11:303-310.
24. Jan M., Lin J., Liau J., Lin Y., Lin D. Investigation of clinical effects of high- and low-resistance training for patients with knee osteoarthritis: a randomized control-led trial. Phys Ther 2008, 88:427-436.
25. Rosemffet M., Schneeberger E., Citera G., Sgobba M., Laiz C., Schmulevich H., et al. Effects of functional electrostimulation on pain, muscular strength, and functional capacity in patients with osteoarthritis of the knee. J Clin Rheumatol 2004, 10:246-249.
26. O'Reilly S.C., Muir K.R., Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis 1999, 58:15-19.
27. Thomas K.S., Muir K.R., Doherty M., Jones A.C., O'Reilly S.C., Bassey E.J., et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. Br Med J 2002, 325:752-755.
28. Baker K.R., Nelson M.E., Felson D.T., Layne J.E., Sarno R., Roubenoff R. The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial. J Rheumatol 2001, 28:1655-1665.
29. Lynch G., Schertzer J., Ryall J. Anabolic agents for improving muscle regeneration and function after injury. Clin Exp Rheumatol Physiol 2008, 35:852-858.
30. Pap G., Machner A., Awiszus F. Strength and voluntary activation of the quadriceps femoris muscle at different severities of osteoarthritic knee joint damage. J Orthop Res 2004, 22:96-103.
31. Fink B., Egl M., Singer J., Fuerst M., Bubenheim M., Neuen-Jacob E. Morphologic changes in the vastus medialis muscle in patients with osteoarthritis of the knee. Arthritis Rheum 2007, 56:3626-3633.
32. Nakamura T., Suzuki K. Changes in osteoarthritis of the hip and knee. Nippon Seikeigeka Gakkai Zasshi 1992, 66:467-475.
33. Ryall J., Lynch G. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting. Pharmacol Ther 2008, 120:219-232.
34. Maltin C.A., Hay S.M., Delday M.I., Lobley G.E., Reeds P.J. The action of the beta-agonist clenbuterol on protein-metabolism in innervated and denervated phasic muscles. Biochem J 1989, 261:965-971.
35. Herrera N.M., Zimmerman A.N., Dykstra D.D., Thompson L.D.V. Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats. Arch Phys Med Rehabil 2001, 82:930-934.
36. Stevens L., Firinga C., Gohlsch R., Bastide B., Mounier Y., Pette D. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am J Physiol Cell Physiol 2000, 279:C1558-C1563.
37. Carbó N., López-Soriano J., Tarragó T., González O., Llovera M., López-Soriano F.J., et al. Comparative effects of [beta]2-adrenergic agonists on muscle waste associated with tumour growth. Cancer Lett 1997, 115:113-118.
38. Ricart-Firinga C., Stevens L., Canu M., Nemirovskaya T., Mounier Y. Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am J Physiol Cell Physiol 2000, 278:C582-C588.
39. Janusz M., Bendele A., Brown K., Taiwo Y., Hsieh L., Heimeyer S. Induction of osteoarthritis in the rat by surgical tear of the meniscus: inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cartilage 2002, 10:785-791.
40. Ivanavicius S., Ball A., Heapy C., Westwood F., Murray F., Read S. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 2007, 128:272-282.
41. Bradford M.M. Rapid and sensitive method for quantification of microgram quantities of protein utilizing principal of protein-dye binding. Anal Biochem 1976, 72:248-254.
42. Mizunoya W., Wakamatsu J., Tatsumi R., Ikeuchi Y. Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. Anal Biochem 2008, 377:111-113.
43. Talmadge R.J., Roy R.R. Electrophoretic separation of skeletal muscle myosin heavy-chain isoforms. J Appl Phys 1993, 75:2337-2340.
44. Lynch G., Ryall J. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 2008, 88:729-767.
45. Adams G., Haddad F., Baldwink Interaction of chronic creatine depletion and muscle unloading - effects on postural and locomotor muscles. J Appl Phys 1994, 77:1198-1205.
46. Gardiner P., Favron M., Corriveau P. Histochemical and contractile responses of rat medial gastronemius to 2 weeks of complete disuse. Can J Physiol Pharmacol 1992, 70:1075-1081.
47. Rothwell N., Stock M. Effect of selective beta-2-adrenergic agonist (clenbuterol) on energy-balance and body composition in normal and protein-deficient rats. Biosci Rep 1987, 7:933-940.
48. Rothwell N., Stock M., Sudera D. Changes in tissue blood-flow and beta receptor density of skeletal-muscle in rats treated with the beta-2-adrenoceptor agonist clenbuterol. Br J Pharmacol 1987, 90:601-607.
49. Arden N., Nevitt M. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006, 20:3-25.
50. Bendele A., Hulman J. Effects of body-weight restriction on the development and progression of spontaneous osteoarthritis in guinea-pigs. Arthritis Rheum 1991, 34:1180-1184.
51. Hortobagyi T., Westerkamp L., Beam S., Moody J., Garry J., Holbert D., et al. Altered hamstring-quadriceps muscle balance in patients with knee osteoarthritis. Clin Biomech 2005, 20:97-104.
52. Schroeder E., Terk M., Sattler F. Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies. Am J Physiol Endocrinol Metab 2003, 285:E16-E24.
53. Kalichman L., Zhang Y., Niu J., Goggins J., Gale D., Zhu Y., et al. The association between patellar alignment on magnetic resonance imaging and radiographic manifestations of knee osteoarthritis. Arthritis Res Ther 2007, 9.